Navigation Links
Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/14/2009

Cash, cash equivalents and marketable securities totaled $73.4 million at June 30, 2009, which does not include the $25 million received in August 2009 upon signing the license and collaboration agreement with Purdue.

2009 Guidance

Transcept continues to expect full year 2009 research and development expenses to remain consistent with 2008 levels. Full year 2009 general and administrative expenses are expected to increase as compared to 2008 in connection with activities related to the potential commercialization of Intermezzo(R), professional fees related to the merger of Transcept and Novacea and the collaboration agreement between Transcept and Purdue, and administrative infrastructure and professional fees related to our public company status.

Conference Call and Webcast Information

Transcept will host a conference call and webcast on Friday, August 14, 2009 at 8:30 a.m. Eastern time to discuss second quarter 2009 financial results. Telephone numbers for the live conference call are 877-397-0284 (U.S.) or 719-325-4890 (International). The webcast can be accessed on the Investors page of the Transcept website at www.transcept.com and will be available for replay until close of business on August 29, 2009. A playback of the call will be available through August 29, 2009 by dialing 888-203-1112 (U.S.) or 719-457-0820 (International), replay passcode: 2582954.

In the event that any non-GAAP financial information is discussed on the conference call that is not described in this release, related complementary information will be made available on the Investors page of the company's website as soon as practical after the conclusion of the conference call.

About Intermezzo(R)

Intermezzo(R) (zolpidem tartrate sublingual tab
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Transcept Pharmaceuticals to Report Second Quarter 2009 Results
2. Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
3. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
4. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
5. Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009
6. Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
7. Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
8. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
9. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
10. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
11. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , ... August 04, 2015 , ... Statement by Paul ... the introduction of the Mental Health Reform Act of 2015 by Senators ... mental health reform a reality in America. , “This legislation and H.R. ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... it has joined the American Association of Tissue Banks (AATB) as an Affiliate ... its mission “to honor donors, and to save and improve lives by promoting ...
(Date:8/4/2015)... ... August 04, 2015 , ... Rhode Island Medical Imaging (RIMI) is pleased ... Medical Building on Wake Robin Road in Lincoln, RI. This satellite office will ... the most extensive out-patient x-ray hours in the state, which includes evenings and weekends. ...
(Date:8/4/2015)... Los Angeles, California (PRWEB) , ... August 04, ... ... bearing drawer slides to Los Angeles commercial customers. Finding reliable hardware can ... create unfortunate liabilities. When putting an office together or designing a new ...
(Date:8/4/2015)... Mountain View, CA (PRWEB) , ... August 04, ... ... 17th Surgeon General of the United States, Richard Carmona, M.D., M.P.H., FACS, to ... prevents catastrophic medication errors and will save lives," Dr. Carmona said. "I strongly ...
Breaking Medicine News(10 mins):Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3
... brain injury (TBI) affects many Americans: high school athletes, ... of domestic violence, to name a few. Some of ... in our soldiers and veterans returning from Iraq and ... with the Department of Defense to investigate the long-term ...
... Loyola University Chicago Stritch School of Medicine study could ... heart disease and cancer as well as more effective ... author Christopher Wiethoff, PhD, and colleagues report their findings ... Virology . Editors spotlighted the report as one of ...
... that the number of people diagnosed with autism has ... a surge in the number of adults with autism ... that this population may earn less and be employed ... disabilities. Now, an autism expert at the University of ...
... (HealthDay News) -- Studies on the effectiveness of cognitive rehabilitation ... a new report issued by the U.S. Institute of Medicine ... kind of therapy helps such patients regain lost mental and ... for its use. With traumatic brain injury (TBI) now ...
... HealthDay Reporter , TUESDAY, Oct. 11 (HealthDay News) ... pregnancy, may be due to a microscopic battle going on ... and those directed by the mother, a new study suggests. ... the activity of cells in the placenta, the new report ...
... Penn State University chemist has demonstrated the strengths and ... -- a technique used to analyze the surface of ... substances. In the new study, the researchers used computer ... of the alternative method, which is being used by ...
Cached Medicine News:Health News:Looking for a link between seizures and migraine after traumatic brain injury in soldiers 2Health News:Study could help improve gene therapy for heart disease, cancer 2Health News:Researcher identifies autism employment resources, tips for people with autism spectrum disorders 2Health News:Evidence Lacking That Cognitive Rehab Therapy Helps Brain-Injured Vets 2Health News:Evidence Lacking That Cognitive Rehab Therapy Helps Brain-Injured Vets 3Health News:Study Suggests Origins of Pregnancy-Linked High Blood Pressure 2Health News:Study Suggests Origins of Pregnancy-Linked High Blood Pressure 3Health News:Molecular depth profiling modeled using buckyballs and low-energy argon 2Health News:Molecular depth profiling modeled using buckyballs and low-energy argon 3
(Date:8/4/2015)... Young Innovations ("Young"), a leading global ... the acquisition of the professional dental contract manufacturing ... MPL PDCMD manufactures fluoride varnish, prophy paste and ... procedures. "This acquisition marks the ... high-growth segments," said Dave Sproat , CEO ...
(Date:8/4/2015)... -- Eli Lilly and Company (NYSE: LLY ) today ... its intent to end its contract with the university ... Alzheimer,s disease (A4) study. The A4 study is a ... of Alzheimer,s disease in older individuals who have evidence ... but do not show symptoms of memory impairment. A4 ...
(Date:8/4/2015)... 2015  IRIDEX Corporation (Nasdaq: IRIX ) today ... served as chief financial officer since 2008 and as ... with the Company, effective August 21, 2015, to accept ... Mackaness intends to continue to serve in the CFO/COO ... 10-Q filing. CEO William M. ...
Breaking Medicine Technology:Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2
... , , , , ... Amira Pharmaceuticals, Inc. announced today the submission of an Investigational New ... the treatment and control of inflammatory and allergic disease linked to ... , , AM461 is an oral, selective antagonist ...
... , JERUSALEM, August 18 ... of alternative drug,delivery systems, announced today that Oramed,s Chief ... overview of the clinical,development of Oramed,s Oral Insulin capsule ... Manchester, England on,September 9, 2009. , ...
Cached Medicine Technology:Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461 2Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: